Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.

Adv Ther · 2020 · PMC7444357 · PMID 32647911

Europe PMC DOI

hedged sentence

0.2830

closest p · 5.7× alpha

0.2830

boldest claim

The sentences

did not reach statistical significancep = 0.283not close (p > 0.1)

At the end of treatment, patients receiving FF/UMEC/VI also had statistically significantly higher odds of being in a better response category versus a worse category for change in activity limitation compared with the previous visit than patients treated with FF/VI ( p = 0.003); the difference for UMEC/VI did not reach statistical significance ( p = 0.283, Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.